查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715301

生物可吸收聚合物市场按产品类型、形式、製造流程、材料类型、应用和最终用户划分—2025-2030 年全球预测

Bioresorbable Polymers Market by Product, Form, Manufacturing Process, Material Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

生物可吸收聚合物市场预计将从 2024 年的 9.9848 亿美元成长到 2025 年的 11.0103 亿美元，复合年增长率为 10.51%，到 2030 年将达到 18.193 亿美元。

主要市场统计数据
基准年2024年 9.9848亿美元
预计年份：2025年 1,101,030,000美元
预测年份 2030 18.193亿美元
复合年增长率（%） 10.51%

生物可吸收聚合物具有独特的生物分解性和功能性组合，是生物医学和製造领域的前沿技术。近年来，随着医疗保健和先进製造业对永续、患者友善解决方案的需求不断增加，这些材料变得越来越重要。生物可吸收聚合物的固有特性使其能够在体内安全分解，从而无需手术切除并降低长期併发症的风险。这项技术进步不仅彻底改变了医疗程序，也为药物输送系统、组织工程和医疗植入的新可能性铺平了道路。

材料科学的快速进步、研发投入的增加以及对以患者为中心的医疗解决方案的日益重视推动了生物可吸收聚合物的发展。此外，製造流程变得越来越复杂，以确保这些材料的性能、可靠性和安全性符合严格的监管标准。随着控制释放、心血管和整形外科植入技术以及再生医学等领域的新兴应用，该市场有望对临床结果和生产效率产生变革性影响。

本执行摘要全面概述了当前的市场动态，并对产品创新、细分研究和区域成长趋势进行了深入分析。随着生物可吸收聚合物领域的不断发展，了解关键驱动因素、挑战和机会对于希望在这个充满活力的市场中竞争的相关人员至关重要。

改变生物可吸收聚合物市场

由于技术创新、监管环境的演变和医疗需求的变化，生物可吸收聚合物的市场格局正在发生重大变化。聚合物化学和加工技术的最新突破扩大了生物可吸收聚合物的用途，使其用途广泛，可用于许多现代医疗产业的应用。传统材料现在正被生物可吸收材料所补充或取代，以确保更安全、更有效的结果，特别是在材料长期存在可能存在风险的领域。

製造流程的进步简化了生产流程、降低了成本并能够精确生产具有理想降解特性的聚合物。相关人员目前看到从传统的萃取和加工技术转向强调效率和生物相容性的更永续的方法的转变。同时，全球对环保产品日益增长的需求正在影响材料的选择和开发，进一步加速生物可吸收聚合物在各个领域的整合。

市场相关人员正在利用这些变化，大力投资研发以提高产品性能，并建立策略伙伴关係以实现创新解决方案商业化。这种变化也反映在监管环境中，加强的安全指南确保生物可吸收产品符合患者照护的最高标准。这种由科学和经济需求共同驱动的竞争环境创造了一个市场舞台，在这个舞台上，成功的适应可以带来巨大的回报。

市场分析的关键细分洞察

生物可吸收聚合物市场根据各种参数进行复杂细分，为该领域的商业机会提供了多方面的视角。对单一产品的详细评估表明，已经开发出纤维、薄膜、微粒和奈米材料等创新产品，每种产品都为特定应用提供了专门的特性。透过形态分析，这些材料进一步分为液体、粉末和固体，突显了满足不同工业和医疗需求所需的多功能性。

此外，仔细考虑吹塑成型、挤压和射出成型等製造流程可以揭示如何客製化製造技术以优化这些聚合物的性能。根据製造方法的不同，最终产品可以表现出对其应用很重要的不同特性，无论是精密医疗植入或控制释放机制。

材料类型，分为聚酸酐、聚己内酯（PCL）、Polyglycolic（PGA）、聚羟基烷酯（PHA）、聚乳酸（PLA）是另一个重要的细分角度。每种材料在可降解性和机械强度方面都表现出独特的性能，影响它们对医疗设备製造和再生医学中各种专门任务的适用性。

当考虑应用时，很明显生物可吸收聚合物在药物传输系统、医疗植入、组织工程和创伤治疗装置中至关重要。例如，药物输送系统被优化为控制释放製剂和特异性载体，医疗植入被设计成具有心血管支架和整形外科植入的专门功能。同样，组织工程将受益于支架设计和干细胞支架技术，而创伤治疗装置将结合黏合剂溶液和敷料材料，以促进患者的康復。根据最终用户，市场遍布生技公司、医院诊所、製药公司、研究机构等。这种市场细分框架允许有针对性的策略发展，并反映了生物可吸收聚合物市场的多样化应用和技术复杂性。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 手术中越来越多地使用生物可吸收缝线和植入
      • 生物可吸收聚合物在聚合物药物传递和3D列印医疗植入中的应用日益增多
      • 部分外科手术的优惠报销政策
    • 限制因素
      • 生产生物可吸收聚合物所需的原料供应有限
    • 机会
      • 创新整形外科植入和手术器械的持续进步
      • 政府支持生物基生物可吸收聚合物的研发
    • 任务
      • 生物可吸收聚合物的技术限制与性能问题
  • 市场区隔分析
    • 产品：生物可吸收聚合物纤维在医用缝线和组织工程领域前景看好
    • 应用：拓展生物可吸收聚合物在组织工程的应用
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章生物可吸收聚合物市场（依产品）

  • 介绍
  • 纤维
  • 电影
  • 微粒
  • 奈米材料

7. 生物可吸收聚合物市场（依形态）

  • 介绍
  • 液体
  • 粉末
  • 固体的

第 8 章生物可吸收聚合物市场（依製造製程）

  • 介绍
  • 吹塑成型
  • 挤压
  • 射出成型

第九章生物可吸收聚合物市场（依材料类型）

  • 介绍
  • 聚酸酐
  • 聚己内酯（PCL）
  • Polyglycolic（PGA）
  • 聚羟基烷酯（PHA）
  • 聚乳酸（PLA）

第 10 章生物可吸收聚合物市场（依应用）

  • 介绍
  • 药物输送系统
    • 控释製剂
    • 针对特定车辆
  • 医疗植入
    • 心血管支架
    • 整形外科植入
  • 组织工程
    • 骨架设计
    • 干细胞支架
  • 创伤治疗装置
    • 黏合剂解决方案
    • 包扎材料

第 11 章生物可吸收聚合物市场（依最终使用者）

  • 介绍
  • 生技公司
  • 医院和诊所
  • 製药公司
  • 研究所

12. 美洲生物吸收性聚合物市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太生物可吸收聚合物市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

14. 欧洲、中东和非洲生物可吸收聚合物市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 3D BIoTek LLC
  • Acuro Organics Limited
  • Advanced Polymer Materials Inc.
  • Anhui Jumei Biological Technology Co., Ltd.
  • Ashland Inc.
  • Avantium NV
  • BMG Incorporated
  • CD Bioparticles
  • Corbion NV
  • Evonik Industries AG
  • Foster Corporation
  • Futerro Group
  • Galatea Surgical, Inc.
  • Huizhou Foryou Medical Devices Co., Ltd.
  • Koninklijke DSM NV
  • MAST Biosurgery
  • Merck KGaA
  • Mitsui & Co., Ltd.
  • Nanosoft Polymers
  • Nomisma Healthcare Pvt. Ltd.
  • Otto Chemie Pvt. Ltd.
  • Poly-Med Incorporated
  • PolyNovo Limited
  • Polysciences, Inc.
  • Putnam Plastics
  • REVA Medical, LLC
  • Rivika Bio Industries Pvt. Ltd.
  • SEQENS SAS
  • Solanyl Biopolymers Inc.
  • SpecialChem SA
  • Stahl Holdings BV
  • Torise Biomaterials Co.,Ltd.
  • UBQ Materials Ltd.
  • Vibha Ecopac Pvt Ltd.
  • Zeus Industrial Products, Inc.
Product Code: MRR-437D45957EE1

The Bioresorbable Polymers Market was valued at USD 998.48 million in 2024 and is projected to grow to USD 1,101.03 million in 2025, with a CAGR of 10.51%, reaching USD 1,819.30 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 998.48 million
Estimated Year [2025] USD 1,101.03 million
Forecast Year [2030] USD 1,819.30 million
CAGR (%) 10.51%

Bioresorbable polymers represent a cutting-edge frontier in the biomedical and manufacturing sectors, offering a unique combination of biodegradability and functionality. In recent years, these materials have gained significant importance as the demand for sustainable and patient-friendly solutions in healthcare and advanced manufacturing has increased. The inherent properties of bioresorbable polymers allow them to safely degrade within the body, eliminating the need for surgical removal and reducing long-term complications. This innovation is not only revolutionizing medical procedures but also paving the way for new possibilities in drug delivery systems, tissue engineering, and medical implants.

The evolution of bioresorbable polymers has been accelerated by rapid advancements in material science, increased R&D investments, and a growing emphasis on patient-centric healthcare solutions. Manufacturing processes have also become more sophisticated, ensuring that the performance, reliability, and safety of these materials meet stringent regulatory standards. With emerging applications in sectors such as controlled drug release, cardiovascular and orthopedic implant technology, and regenerative medicine, this market is poised to establish a transformative impact on both clinical outcomes and production efficiencies.

This executive summary presents a comprehensive overview of the current market dynamics, supported by deep-dive analyses into product innovations, segmentation studies, and regional growth trends. As the landscape of bioresorbable polymers continues to evolve, understanding the key drivers, challenges, and opportunities becomes essential for stakeholders seeking a competitive edge in this dynamic market.

Transformative Shifts in the Market Landscape

The landscape of the bioresorbable polymers market is undergoing transformative shifts driven by technological innovations, evolving regulatory frameworks, and changing healthcare demands. Recent breakthroughs in polymer chemistry and processing techniques have expanded the applications of these materials, making them versatile enough for a host of modern medical and industrial applications. Traditional materials are now being supplemented or replaced by bioresorbable options, ensuring safer and more efficient outcomes, particularly in areas where long-term material presence can pose a risk.

Advancements in manufacturing processes have streamlined production, reduced costs, and enabled higher precision in fabricating polymers with desirable degradation profiles. Stakeholders are now witnessing a shift from conventional extraction and processing techniques to more sustainable methods that emphasize efficiency and biocompatibility. At the same time, the global push for environmentally conscious products is influencing how materials are selected and developed, further accelerating the integration of bioresorbable polymers in a variety of sectors.

Market players are leveraging these changes by investing heavily in R&D to refine product performance and by forming strategic partnerships to commercialize innovative solutions. The transformation is also evident in the regulatory landscape, where enhanced safety guidelines ensure that bioresorbable products meet the highest standards for patient care. This environment of change, driven by both scientific and economic imperatives, sets the stage for a competitive market where successful adaptation can lead to significant rewards.

Key Segmentation Insights for Market Analysis

The bioresorbable polymers market is intricately segmented based on various parameters that together frame a multi-dimensional view of the sector's opportunities. A deep evaluation by product reveals that innovations are being developed across fibers, films, micro-particles, and nanomaterials, each offering distinctive properties for specific applications. Analysis based on form further categorizes these materials into liquid, powder, and solid, highlighting the versatility needed to meet diverse industrial and healthcare requirements.

In addition, a careful review of manufacturing processes such as blow molding, extrusion, and injection molding sheds light on how production techniques are tailored to optimize the performance of these polymers. Depending on the manufacturing method, the end product may exhibit varying characteristics that are crucial for its application, whether that be in a high-precision medical implant or a controlled drug release mechanism.

Material type serves as another important segmentation angle, with classifications into polyanhydrides, polycaprolactone (PCL), polyglycolic acid (PGA), polyhydroxyalkanoate (PHA), and polylactic acid (PLA). Each of these materials presents a unique set of properties in terms of degradability and mechanical strength, influencing their suitability for a range of specialized tasks in medical device manufacturing and regenerative medicine.

When examining applications, it becomes clear that bioresorbable polymers are pivotal in drug delivery systems, medical implants, tissue engineering, and wound healing devices. A closer look reveals further granularity; for instance, drug delivery systems are optimized as controlled release formulations and target-specific vehicles, while medical implants are designed with specialized features for cardiovascular stents and orthopedic implants. Similarly, tissue engineering benefits from scaffold designs and stem cell scaffolding techniques, and wound healing devices incorporate adhesive solutions and bandaging materials to enhance patient recovery. Exploring the end-user dimension, the market stretches across biotechnology companies, hospitals and clinics, pharmaceutical companies, and research institutes. This segmentation framework allows for targeted strategy development and reflects the diverse range of applications and technological intricacies within the bioresorbable polymers market.

Based on Product, market is studied across Fibers, Films, Micro-Particles, and Nanomaterials.

Based on Form, market is studied across Liquid, Powder, and Solid.

Based on Manufacturing Process, market is studied across Blow Molding, Extrusion, and Injection Molding.

Based on Material Type, market is studied across Polyanhydrides, Polycaprolactone (PCL), Polyglycolic Acid (PGA), Polyhydroxyalkanoate (PHA), and Polylactic Acid (PLA).

Based on Application, market is studied across Drug Delivery Systems, Medical Implants, Tissue Engineering, and Wound Healing Devices. The Drug Delivery Systems is further studied across Controlled Release Formulations and Target-Specific Vehicles. The Medical Implants is further studied across Cardiovascular Stents and Orthopedic Implants. The Tissue Engineering is further studied across Scaffold Designs and Stem Cell Scaffolding. The Wound Healing Devices is further studied across Adhesive Solutions and Bandaging Materials.

Based on End-User, market is studied across Biotechnology Companies, Hospitals and Clinics, Pharmaceutical Companies, and Research Institutes.

Key Regional Insights and Growth Opportunities

The global market for bioresorbable polymers can be characterized by its regional diversity, with significant growth observed in the Americas, Europe, Middle East & Africa, and the Asia-Pacific regions. In the Americas, advanced healthcare systems and robust research infrastructure foster an environment conducive to the rapid adoption of innovative bioresorbable solutions. This region benefits from established manufacturing capabilities and strong governmental support, all of which accelerate market penetration and infrastructural development.

Europe, Middle East & Africa offer a unique blend of stringent regulatory demands and meticulous quality controls that drive innovation in bioresorbable materials. The region is marked by an increasing focus on sustainability, which aligns with the environmentally friendly nature of these polymers, spurring both industrial and clinical research initiatives.

Asia-Pacific stands out as a dynamic market driven by fast-paced technological advancements and an expanding consumer base. Strong government initiatives supporting research and development, combined with rapidly growing healthcare and biotechnology sectors, have positioned the region as a hub for both innovation and manufacturing. These regional advantages are instrumental in shaping the future trajectory of the market, as industry players tailor their strategies to cater to the specific needs and regulatory frameworks of each area.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Catalyzing Market Innovation

The bioresorbable polymers market is marked by the strategic maneuvers of several leading companies that are driving innovation and setting benchmarks for performance. Industry pioneers such as 3D Biotek LLC and Acuro Organics Limited have been instrumental in advancing the product portfolio by investing in state-of-the-art production techniques. Global players like Advanced Polymer Materials Inc. and Anhui Jumei Biological Technology Co., Ltd. continue to push the boundaries in development, taking a holistic approach to integrate research with market needs.

Established entities like Ashland Inc. and Avantium N.V. have demonstrated robust capabilities in both capturing and expanding market share, while BMG Incorporated and CD Bioparticles focus on niche applications that address specific clinical challenges. Companies such as Corbion NV and Evonik Industries AG are well-known for their commitment to quality and innovation, consistently refining the properties of bioresorbable polymers to meet more critical demand spikes. This drive for excellence is further bolstered by the contributions of Foster Corporation, Futerro Group, and Galatea Surgical, Inc., whose strategies are oriented towards combining creative engineering with regulatory compliance.

Huizhou Foryou Medical Devices Co., Ltd., Koninklijke DSM N.V., and MAST Biosurgery provide comprehensive solutions that have resulted in increased efficacy and greater patient safety. Meanwhile, Merck KGaA, Mitsui & Co., Ltd., and Nanosoft Polymers continue to strengthen their market positions by leveraging decades of expertise to foster innovation and productivity. Notably, Nomisma Healthcare Pvt. Ltd., Otto Chemie Pvt. Ltd., and Poly-Med Incorporated maintain a steadfast focus on application-specific solutions, underpinning their offerings with thorough research and robust production methods. With a dynamic mix of established and emerging players such as PolyNovo Limited, Polysciences, Inc., Putnam Plastics, and REVA Medical, LLC, the landscape remains highly competitive and ripe with opportunities for further innovation. Rivika Bio Industries Pvt. Ltd., SEQENS SAS, Solanyl Biopolymers Inc., SpecialChem S.A., Stahl Holdings B.V., Torise Biomaterials Co.,Ltd., UBQ Materials Ltd., Vibha Ecopac Pvt Ltd., and Zeus Industrial Products, Inc. collectively illustrate the scale and diversity of the market, each leveraging their unique strengths to address evolving customer needs and industry trends.

The report delves into recent significant developments in the Bioresorbable Polymers Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, Acuro Organics Limited, Advanced Polymer Materials Inc., Anhui Jumei Biological Technology Co., Ltd., Ashland Inc., Avantium N.V., BMG Incorporated, CD Bioparticles, Corbion NV, Evonik Industries AG, Foster Corporation, Futerro Group, Galatea Surgical, Inc., Huizhou Foryou Medical Devices Co., Ltd., Koninklijke DSM N.V., MAST Biosurgery, Merck KGaA, Mitsui & Co., Ltd., Nanosoft Polymers, Nomisma Healthcare Pvt. Ltd., Otto Chemie Pvt. Ltd., Poly-Med Incorporated, PolyNovo Limited, Polysciences, Inc., Putnam Plastics, REVA Medical, LLC, Rivika Bio Industries Pvt. Ltd., SEQENS SAS, Solanyl Biopolymers Inc., SpecialChem S.A., Stahl Holdings B.V., Torise Biomaterials Co.,Ltd., UBQ Materials Ltd., Vibha Ecopac Pvt Ltd., and Zeus Industrial Products, Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to closely monitor emerging trends and invest in R&D initiatives that focus on enhancing product performance and manufacturing efficiency. Strategic collaborations and partnerships across sectors are essential to tap into diverse applications and to respond swiftly to ever-changing regulatory environments. Emphasizing customer-centric design and robust quality assurance practices will further strengthen market positioning in this competitive landscape. Leaders should also prioritize sustainability and compliance, ensuring that each step in the development cycle aligns with best practices while maximizing patient safety and environmental impacts.

Conclusion and Future Outlook

In conclusion, the market for bioresorbable polymers is at an exciting inflection point, characterized by rapid technological advancement and expanding applications across diverse sectors. The increasing adoption of innovative manufacturing processes, coupled with targeted segmentation strategies, is paving the way for sustainable and clinically effective solutions. As industry leaders continue to leverage new research and adapt to evolving regulatory frameworks, the future of bioresorbable polymers appears promising, with clear pathways for growth and innovation. Continuous improvements in material science and production methodology are expected to further bolster the market's potential, making this a fertile ground for investment and strategic expansion.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing usage of bioresorbable sutures and implants in surgical procedures
      • 5.1.1.2. Growing adoption of bioresorbable polymers for polymeric drug delivery and 3D printed medical implants
      • 5.1.1.3. Favorable reimbursement policies for several surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of raw materials for the production of bioresorbable polymers
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in innovative orthopedic implants and surgical devices
      • 5.1.3.2. Supportive government initiatives in research and development of bio-based bioresorbable polymer
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and performance issues in bioresorbable polymers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing preference for bioresorbable polymer fibers in medical sutures and tissue engineering
    • 5.2.2. Application: Expanding application of bioresorbable polymers in tissue engineering
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioresorbable Polymers Market, by Product

  • 6.1. Introduction
  • 6.2. Fibers
  • 6.3. Films
  • 6.4. Micro-Particles
  • 6.5. Nanomaterials

7. Bioresorbable Polymers Market, by Form

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Powder
  • 7.4. Solid

8. Bioresorbable Polymers Market, by Manufacturing Process

  • 8.1. Introduction
  • 8.2. Blow Molding
  • 8.3. Extrusion
  • 8.4. Injection Molding

9. Bioresorbable Polymers Market, by Material Type

  • 9.1. Introduction
  • 9.2. Polyanhydrides
  • 9.3. Polycaprolactone (PCL)
  • 9.4. Polyglycolic Acid (PGA)
  • 9.5. Polyhydroxyalkanoate (PHA)
  • 9.6. Polylactic Acid (PLA)

10. Bioresorbable Polymers Market, by Application

  • 10.1. Introduction
  • 10.2. Drug Delivery Systems
    • 10.2.1. Controlled Release Formulations
    • 10.2.2. Target-Specific Vehicles
  • 10.3. Medical Implants
    • 10.3.1. Cardiovascular Stents
    • 10.3.2. Orthopedic Implants
  • 10.4. Tissue Engineering
    • 10.4.1. Scaffold Designs
    • 10.4.2. Stem Cell Scaffolding
  • 10.5. Wound Healing Devices
    • 10.5.1. Adhesive Solutions
    • 10.5.2. Bandaging Materials

11. Bioresorbable Polymers Market, by End-User

  • 11.1. Introduction
  • 11.2. Biotechnology Companies
  • 11.3. Hospitals and Clinics
  • 11.4. Pharmaceutical Companies
  • 11.5. Research Institutes

12. Americas Bioresorbable Polymers Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Bioresorbable Polymers Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Bioresorbable Polymers Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Sonavex Inc. raises USD 15 million in Series A-2 funding
    • 15.3.2. The POLYMEER initiative, funded with EUR 4.9 million by the circular bio-based Europe joint undertaking HORIZON program
    • 15.3.3. Ashland completes its second expansion of the Viatel bioresorbable polymers manufacturing and R&D lab
    • 15.3.4. Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
    • 15.3.5. Evonik backs Allay's development of pain therapy implants
    • 15.3.6. Collagen matrix acquires polyganics
    • 15.3.7. Technip energies acquires Biosuccinium technology from DSM for bio-sourced and fully biodegradable polymers production
    • 15.3.8. Ashland expands bioresorbable development site in Ireland
    • 15.3.9. Biotech startup String Bio raises $20M in funding from Woodside Energy Group, others
    • 15.3.10. Amerigo scientific launches polycaprolactone for bioprinting
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D Biotek LLC
  • 2. Acuro Organics Limited
  • 3. Advanced Polymer Materials Inc.
  • 4. Anhui Jumei Biological Technology Co., Ltd.
  • 5. Ashland Inc.
  • 6. Avantium N.V.
  • 7. BMG Incorporated
  • 8. CD Bioparticles
  • 9. Corbion NV
  • 10. Evonik Industries AG
  • 11. Foster Corporation
  • 12. Futerro Group
  • 13. Galatea Surgical, Inc.
  • 14. Huizhou Foryou Medical Devices Co., Ltd.
  • 15. Koninklijke DSM N.V.
  • 16. MAST Biosurgery
  • 17. Merck KGaA
  • 18. Mitsui & Co., Ltd.
  • 19. Nanosoft Polymers
  • 20. Nomisma Healthcare Pvt. Ltd.
  • 21. Otto Chemie Pvt. Ltd.
  • 22. Poly-Med Incorporated
  • 23. PolyNovo Limited
  • 24. Polysciences, Inc.
  • 25. Putnam Plastics
  • 26. REVA Medical, LLC
  • 27. Rivika Bio Industries Pvt. Ltd.
  • 28. SEQENS SAS
  • 29. Solanyl Biopolymers Inc.
  • 30. SpecialChem S.A.
  • 31. Stahl Holdings B.V.
  • 32. Torise Biomaterials Co.,Ltd.
  • 33. UBQ Materials Ltd.
  • 34. Vibha Ecopac Pvt Ltd.
  • 35. Zeus Industrial Products, Inc.

LIST OF FIGURES

  • FIGURE 1. BIORESORBABLE POLYMERS MARKET MULTI-CURRENCY
  • FIGURE 2. BIORESORBABLE POLYMERS MARKET MULTI-LANGUAGE
  • FIGURE 3. BIORESORBABLE POLYMERS MARKET RESEARCH PROCESS
  • FIGURE 4. BIORESORBABLE POLYMERS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. BIORESORBABLE POLYMERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. BIORESORBABLE POLYMERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIORESORBABLE POLYMERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIORESORBABLE POLYMERS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 157. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 167. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 168. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 177. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 178. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 179. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 188. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 197. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 198. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 199. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 200. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 217. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 218. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 219. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 227. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 228. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 229. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 230. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 237. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 238. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 239. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 240. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 259. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 260. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 261. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 269. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 270. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 278. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 279. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 280. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 281. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 288. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 289. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 290. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 291. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 298. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 299. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 300. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 301. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 308. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 309. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 310. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 311. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 318. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 319. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 320. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 321. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 328. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)

TABLE 33